Frovatriptan and Rizatriptan Economic EVAluation: the FREEVA study

BACKGROUND: The present pharmacoeconomic study compared the direct and indirect costs of using frovatriptan versus rizatriptan in the acute treatment of migraine. METHODS: Data on the cost-efficacy of the two triptans were derived from a recently published Italian, multicenter, randomized, double-bl...

Descripción completa

Detalles Bibliográficos
Autores principales: Lisotto, Carlo, Guidotti, Mario, Zava, Dario, Savi, Lidia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3878870/
https://www.ncbi.nlm.nih.gov/pubmed/24330707
http://dx.doi.org/10.1186/1129-2377-14-96

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3878870/
https://www.ncbi.nlm.nih.gov/pubmed/24330707
http://dx.doi.org/10.1186/1129-2377-14-96

Ejemplares similares